The Detroit project envisioned using JavaScript as an extension language for Java applications. Now it’s being revived with ...

Java and JavaScript are entirely different languages despite their similar names. Java is compiled and widely used for ...

Vercept’s first investor was a Seattle-based startup incubator called AI2 Incubator. The organization started out as a unit ...

A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...

The Microsoft Defender team has discovered a coordinated campaign targeting software developers through malicious repositories posing as legitimate Next.js projects and technical assessment materials, ...

Four rogue NuGet packages and one npm package stole ASP.NET Identity data, deployed C2 backdoors, and reached over 50,000 ...

The recently unveiled x86CSS project aims to emulate an x86 processor within a web browser. Unlike many other web-based ...

First registrational study to specifically evaluate a targeted treatment for patients living with ocular MGResults support planned Supplemental Biologics License Application (sBLA) submission to ...

Just like algae blooms in the ocean and pollen in the spring, there’s been an explosion in the past year or two of new software, related tools and lingo from the IT and mainstream/consumer side. Some ...

Version 2.7 of the runtime for JavaScript and TypeScript stabilizes the Temporal API, introduces npm overrides, and ...

Bresler and Milardo met through a mutual colleague. A month after the initial conversation, Milardo became the company’s chief technology officer. Two months after that, she was a co-founder.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for olezarsen ...